| |
DS-specific AML protocol (N = 12)
|
Non-DS specific AML protocol (N = 38)
|
|---|
|
Sterile site bacteria*
| | |
|
Gram positive
| | |
|
Viridans group streptococci
|
5
|
4
|
|
Coagulase negative staphylococci
|
0
|
3
|
|
Enterococcus faecalis
|
0
|
2
|
|
Othera
|
0
|
1
|
|
Gram negative
| | |
|
Escherichia coli
|
1
|
3
|
|
Klebsiella pneumoniae
|
0
|
1
|
|
Enterobacter cloacae
|
0
|
2
|
|
Othersb
|
1
|
2
|
|
Fungus*
| | |
|
Candida species
|
0
|
2
|
|
Virus*
| | |
|
Herpes simplex virus
|
1
|
1
|
|
Respiratory syncytial virus
|
1
|
3
|
|
Torovirus
|
1
|
4
|
|
Othersc
|
1
|
5
|
|
Clostridium difficile*
|
1
|
5
|
- Abbreviations: AML acute myeloid leukemia, DS Down syndrome.
- *For bacterial infections other than C. difficile, only sterile site positive cultures are shown. For fungi, viruses and C. difficile, both sterile and non-sterile site positive cultures are shown.
- aOther: beta-hemolytic Streptococcus (n = 1).
- bOthers: Citrobacter freundii (n = 1) for Down syndrome protocol group; Enterobacter species (n = 1) and Haemophilus influenza (n = 1) for non-Down syndrome protocol group.
- cOther: parvovirus (n = 1) for Down syndrome protocol group; parainfluenza (n = 3) and rotavirus (n = 2) for non-Down syndrome protocol group.
